Larvol Delta - ATX295001-FirstinHuman-Study-of-ATX295-an-Oral-Inhibitor-of-KIF18A-in-Patients-With-Advanced-or-Metastatic-Solid-Tumors-Including-Ovarian-Cancer

ATX-295 - Accent Therap

http://clinicaltrials.gov/ct2/show/NCT06799065

Jan 3, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next